Skip to main content

Advertisement

Articles

Page 3 of 4

  1. Osteosarcoma is the most common primary malignant bone tumor in children and young adults. Ganglioside GD2 has been previously found on the cell surface in various tumor types, including osteosarcomas.

    Authors: Vincent I Poon, Michael Roth, Sajida Piperdi, David Geller, Jonathan Gill, Erin R Rudzinski, Douglas S Hawkins and Richard Gorlick

    Citation: Clinical Sarcoma Research 2015 5:4

    Content type: Short Report

    Published on:

  2. Pulmonary artery sarcoma (PAS) is a rare but aggressive malignancy that leads to heart failure and death without treatment. Here we reviewed the presentation and management of patients treated at a national ce...

    Authors: Han Hsi Wong, Ioannis Gounaris, Ann McCormack, Marius Berman, Dochka Davidson, Gail Horan, Joanna Pepke-Zaba, David Jenkins, Helena M Earl and Helen M Hatcher

    Citation: Clinical Sarcoma Research 2015 5:3

    Content type: Research

    Published on:

  3. Tyrosine kinase inhibitors (TKI) have revolutionized the treatment of gastrointestinal

    Authors: Attila Kollàr, Marco Maruzzo, Christina Messiou, Elisabeth Cartwright, Aisha Miah, Juan Martin-Liberal, Khin Thway, Ellen McGrath, Alison Dunlop, Komel Khabra, Beatrice Seddon, Palma Dileo, Mark Linch, Ian Judson and Charlotte Benson

    Citation: Clinical Sarcoma Research 2014 4:17

    Content type: Research

    Published on:

  4. Liposarcomas represent the most common histological type of soft-tissue sarcomas (STS). Its main subgroups, WD/DD, is known to be poorly sensitive to chemotherapy, with few active agents, i.e., anthracyclines ...

    Authors: Roberta Sanfilippo, Rossella Bertulli, Andrea Marrari, Elena Fumagalli, Silvana Pilotti, Carlo Morosi, Antonella Messina, Angelo Paolo Dei Tos, Alessandro Gronchi and Paolo Giovanni Casali

    Citation: Clinical Sarcoma Research 2014 4:16

    Content type: Research

    Published on:

  5. An increased risk of posttransplant malignancy has been consistently reported following various solid organ transplants. The malignancies most commonly encountered are non-melanoma skin cancers, carcinomas of ...

    Authors: Lea N Baer, David G Savage, Hanina H Hibshoosh and Kevin Kalinsky

    Citation: Clinical Sarcoma Research 2014 4:15

    Content type: Case Report

    Published on:

  6. Recently, the phase III PALETTE study introduced pazopanib (Votrient®) as treatment for adult patients with locally advanced or metastatic non-liposarcoma soft tissue sarcoma after prior treatment with doxorub...

    Authors: Arie J Verschoor and Hans Gelderblom

    Citation: Clinical Sarcoma Research 2014 4:14

    Content type: Case Report

    Published on:

  7. Hemangiopericytoma is a rare disease entity of soft-tissue sarcoma (STS) that can be cured with surgical resection. In cases of inoperable recurrence or metastasis, palliative chemotherapy is indicated, though...

    Authors: Su Jin Lee, Seung Tae Kim, Se Hoon Park, Yoon La Choi, Jae Berm Park, Sung-Joo Kim and Jeeyun Lee

    Citation: Clinical Sarcoma Research 2014 4:13

    Content type: Case Report

    Published on:

  8. We report multiple synchronous clear-cell chondrosarcomas in a 43-year-old patient. The patient had a lesion in the right proximal humerus and in the left femoral condyle. Bone scintigraphy revealed increased ...

    Authors: Marco Manfrini, Silvana Fiscina, Alberto Righi, Jorge M Montes and Daniel Vanel

    Citation: Clinical Sarcoma Research 2014 4:12

    Content type: Case Report

    Published on:

  9. The majority of patients with chondrosarcoma of bone have an excellent overall survival after local therapy. However, in case of unresectable locally advanced or metastatic disease the outcome is poor and limi...

    Authors: Annemiek M van Maldegem, Judith VMG Bovée and Hans Gelderblom

    Citation: Clinical Sarcoma Research 2014 4:11

    Content type: Research

    Published on:

  10. Acquired resistance to tyrosine kinase inhibitors (TKIs) in gastrointestinal stromal tumours (GISTs) is most commonly caused by secondary KIT or PDGFRA mutations. In this study we characterize a newly established...

    Authors: Thomas Van Looy, Yemarshet Kelemework Gebreyohannes, Agnieszka Wozniak, Jasmien Cornillie, Jasmien Wellens, Haifu Li, Ulla Vanleeuw, Giuseppe Floris, Maria Debiec-Rychter, Raf Sciot and Patrick Schöffski

    Citation: Clinical Sarcoma Research 2014 4:10

    Content type: Research

    Published on:

  11. Intragenic deletions of the dystrophin-encoding and muscular dystrophy-associated DMD gene have been recently described in gastrointestinal stromal tumor (GIST), rhabdomyosarcoma (RMS) and leiomyosarcoma (LMS). W...

    Authors: Maria A Pantaleo, Annalisa Astolfi, Milena Urbini, Fabio Fuligni, Maristella Saponara, Margherita Nannini, Cristian Lolli, Valentina Indio, Donatella Santini, Giorgio Ercolani, Giovanni Brandi, Antonio D Pinna and Guido Biasco

    Citation: Clinical Sarcoma Research 2014 4:9

    Content type: Short Report

    Published on:

  12. Dermatofibrosarcoma Protuberans (DFSP) is a rare skin tumor, characterized by frequent local recurrence but is seldom metastatic. It is histologically characterized by storiform arrangement of spindle cells. C...

    Authors: Mashaal Dhir, David G Crockett, Todd M Stevens, Peter T Silberstein, William J Hunter and Jason M Foster

    Citation: Clinical Sarcoma Research 2014 4:8

    Content type: Case Report

    Published on:

  13. We retrospectively reviewed data from nine pre-treated metastatic desmoplastic small round cell tumour (DSRCT) patients who received pazopanib.

    Authors: Anna Maria Frezza, Charlotte Benson, Ian R Judson, Saskia Litiere, Sandrine Marreaud, Stefan Sleijfer, Jean-Yves Blay, Raz Dewji, Cyril Fisher, Winette van der Graaf and Larry Hayward

    Citation: Clinical Sarcoma Research 2014 4:7

    Content type: Research

    Published on:

  16. This is the report of the 2nd Joint ENCCA/EuroSARC European Bone Sarcoma Network Meeting held in Leiden, The Netherlands, on 26-27 September 2013, bringing together preclinical and clinical investigators on bone ...

    Authors: Jakob K Anninga, Anne-Marie Cleton-Jansen, Bass Hassan, M Fernanda Amary, Daniel Baumhoer, Jean-Yves Blay, Laurence Brugieres, Stefano Ferrari, Heribert Jürgens, Beate Kempf-Bielack, Heinrich Kovar, Ola Myklebost, Michaela Nathrath, Piero Picci, Peter Riegman, Marco W Schilham…

    Citation: Clinical Sarcoma Research 2014 4:4

    Content type: Meeting Report

    Published on:

  19. Epstein-Barr virus (EBV)-associated post-transplant smooth muscle tumours (PTSMT), are rare complications following organ/stem cell transplantation. Despite the mainly benign behaviour of PTSMT, alternative th...

    Authors: Danny Jonigk, Nicole Izykowski, Lavinia Maegel, Eileen Schormann, Britta Ludewig, Hans Kreipe and Kais Hussein

    Citation: Clinical Sarcoma Research 2014 4:1

    Content type: Research

    Published on:

  20. Extraskeletal myxoid chondrosarcoma (EMC) is a rare subgroup within soft tissue sarcomas. Its sensitivity to chemotherapy is reported to be low.

    Authors: Silvia Stacchiotti, Gian Paolo Dagrada, Roberta Sanfilippo, Tiziana Negri, Isabella Vittimberga, Stefano Ferrari, Federica Grosso, Gaetano Apice, Marco Tricomi, Chiara Colombo, Alessandro Gronchi, Angelo P Dei Tos, Silvana Pilotti and Paolo G Casali

    Citation: Clinical Sarcoma Research 2013 3:16

    Content type: Research

    Published on:

  21. Data suggests that males experience less toxicity and poorer survival than females treated for Ewing’s sarcoma. We instituted an intra-patient dose escalation (DE) policy with Vincristine/Doxorubicin/Cyclophos...

    Authors: Jeremy Lewin, Samantha Wieringa, Marnie Collins, Jayesh Desai, Lisa Orme, Senthil Lingaratnam and David M Thomas

    Citation: Clinical Sarcoma Research 2013 3:15

    Content type: Research

    Published on:

  22. Desmoplastic small round cell tumour (DSRCT) is a rare but frequently fatal sarcoma, and many of its characteristics still require further clarification.

    Authors: Han Hsi Wong, Helen M Hatcher, Charlotte Benson, Omar Al-Muderis, Gail Horan, Cyril Fisher, Helena M Earl and Ian Judson

    Citation: Clinical Sarcoma Research 2013 3:14

    Content type: Research

    Published on:

  23. Desmoid tumours/aggressive fibromatosis (DT/AF) are infrequent soft-tissue neoplasms. They usually behave as indolent diseases. However, they may grow locally infiltrating or compressing adjacent structures. T...

    Authors: Juan Martin-Liberal, Charlotte Benson, Heather McCarty, Khin Thway, Christina Messiou and Ian Judson

    Citation: Clinical Sarcoma Research 2013 3:13

    Content type: Case Report

    Published on:

  24. Gastrointestinal stromal tumors are rare soft tissue sarcomas that typically develop from mesenchymal cells with acquired gain-in-function mutations in KIT or PDGFRA oncogenes. These somatic mutations have been w...

    Authors: Katie M O’Brien, Irene Orlow, Cristina R Antonescu, Karla Ballman, Linda McCall, Ronald DeMatteo and Lawrence S Engel

    Citation: Clinical Sarcoma Research 2013 3:12

    Content type: Research

    Published on:

  25. The study aimed to examine attitudes of individuals diagnosed with sarcoma and their family members towards genetics, genomic research and incidental information arising as a result of participating in genetic...

    Authors: Mary-Anne Young, Amy Herlihy, Gillian Mitchell, David M Thomas, Mandy Ballinger, Kathy Tucker, Craig R Lewis, Susan Neuhaus and Jane Halliday

    Citation: Clinical Sarcoma Research 2013 3:11

    Content type: Research

    Published on:

  26. MSCs are hypothesized to potentially give rise to sarcomas after transformation and therefore serve as a good model to study sarcomagenesis. Both spontaneous and induced transformation of MSCs have been report...

    Authors: Wei Xiao, Alexander B Mohseny, Pancras C W Hogendoorn and Anne-Marie Cleton-Jansen

    Citation: Clinical Sarcoma Research 2013 3:10

    Content type: Review

    Published on:

  27. Epstein-Barr virus (EBV)-associated post-transplant smooth muscle tumours (PTSMT) are rare complications. In our previous molecular analysis, we have evaluated the expression of regulatory microRNA which are k...

    Authors: Danny Jonigk, Nicole Izykowski, Lavinia Maegel, Eileen Schormann, Britta Maecker-Kolhoff, Florian Laenger, Hans Kreipe and Kais Hussein

    Citation: Clinical Sarcoma Research 2013 3:9

    Content type: Research

    Published on:

  28. Pigmented villonodular synovitis (PVNS) is a rare locally aggressive tumor. PVNS is characterized in most cases by a specific t(1;2) translocation, which fuses the colony stimulating factor-1 (CSF1) gene to the c...

    Authors: Silvia Stacchiotti, Flavio Crippa, Antonella Messina, Silvana Pilotti, Alessandro Gronchi, Jean Y Blay and Paolo G Casali

    Citation: Clinical Sarcoma Research 2013 3:8

    Content type: Case Report

    Published on:

  29. Patients with advanced solitary fibrous tumors (SFTs) have a poor prognosis; treatment options for recurrent disease are particularly limited. Several novel targeted agents have recently shown promise against ...

    Authors: Min S Park, Vinod Ravi, Anthony Conley, Shreyaskumar R Patel, Jonathan C Trent, Dina C Lev, Alexander J Lazar, Wei-Lien Wang, Robert S Benjamin and Dejka M Araujo

    Citation: Clinical Sarcoma Research 2013 3:7

    Content type: Research

    Published on:

  30. We surveyed the natural history of bone metastases in patients affected by soft tissue sarcoma (STS).

    Authors: Bruno Vincenzi, Anna Maria Frezza, Gaia Schiavon, Daniele Santini, Palma Dileo, Marianna Silletta, Delia Delisi, Francesco Bertoldo, Giuseppe Badalamenti, Giacomo Giulio Baldi, Stefania Zovato, Rossana Berardi, Marco Tucci, Franco Silvestris, Angelo Paolo Dei Tos, Roberto Tirabosco…

    Citation: Clinical Sarcoma Research 2013 3:6

    Content type: Research

    Published on:

  32. We explore the pattern of late recurrence (LR) in solitary fibrous tumor (SFT), focusing on histopathologic characteristics, clinical presentation and patients (pts) outcome.

    Authors: Giacomo G Baldi, Silvia Stacchiotti, Valentina Mauro, Angelo P Dei Tos, Alessandro Gronchi, Ugo Pastorino, Leonardo Duranti, Salvatore Provenzano, Andrea Marrari, Michela Libertini, Silvana Pilotti and Paolo G Casali

    Citation: Clinical Sarcoma Research 2013 3:4

    Content type: Research

    Published on:

  33. The systemic treatment of malignant endometrial stromal tumors (EST) is not well established. A few reports describe objective responses to imatinib, which suggest a novel therapeutic strategy for these tumors...

    Authors: Ruth Sardinha, Teresa Hernández, Susana Fraile, Francesc Tresserra, August Vidal, Maria Carmén Gómez, Aurora Astudillo, Nieves Hernández, Javier Saenz de Santamaría, Jaume Ordi, Luis Gonçalves, Rafael Ramos, Carmen Balañá and Enrique de Álava

    Citation: Clinical Sarcoma Research 2013 3:3

    Content type: Research

    Published on:

  34. Ewing sarcoma (ES) is a high-grade malignant primary round cell tumour of bone in which there is commonly extension into extraosseous soft tissues at the time of diagnosis. This report details the clinical, ra...

    Authors: Takeshi G Kashima, Nimali G Gamage, Uta Dirksen, Christopher L M H Gibbons, Simon J Ostlere and Nicholas A Athanasou

    Citation: Clinical Sarcoma Research 2013 3:2

    Content type: Research

    Published on:

  36. Trabectedin and thioglitazones have been documented to induce adipocytic maturation in myxoid liposarcoma; we have noted this in our experience as well. Intriguingly, we have also encountered this same phenome...

    Authors: Wei-Lien Wang, Daniela Katz, Dejka M Araujo, Vinod Ravi, Joseph A Ludwig, Jonathan C Trent, Shreyaskumar R Patel, Patrick P Lin, Ashleigh Guadagnolo, Dolores Lòpez-Terrada, Angelo Paola dei Tos, Valerie O Lewis, Dina Lev, Raphael E Pollock, Gunar K Zagars, Robert S Benjamin…

    Citation: Clinical Sarcoma Research 2012 2:25

    Content type: Research

    Published on:

  37. Chemokine receptor CXCR4, together with its ligand CXCL12, plays critical roles in cancer progression, including growth, metastasis and angiogenesis. Ewing sarcoma is a sarcoma with poor prognosis despite curr...

    Authors: Dagmar Berghuis, Marco W Schilham, Susy J Santos, Suvi Savola, Helen J Knowles, Uta Dirksen, Karl-Ludwig Schaefer, Jukka Vakkila, Pancras CW Hogendoorn and Arjan C Lankester

    Citation: Clinical Sarcoma Research 2012 2:24

    Content type: Research

    Published on:

  39. Extraskeletal myxoid chondrosarcoma (EMCS) is a rare soft tissue sarcoma of uncertain differentiation, characterized in most cases by a translocation that results in the fusion protein EWSR1-CHN (the latter even ...

    Authors: Silvia Stacchiotti, Gian Paolo Dagrada, Carlo Morosi, Tiziana Negri, Antonella Romanini, Silvana Pilotti, Alessandro Gronchi and Paolo G Casali

    Citation: Clinical Sarcoma Research 2012 2:22

    Content type: Case Report

    Published on:

  42. Osteosarcoma is the most common form of bone cancer. Pivotal insight into the genes involved in human osteosarcoma has been provided by the study of rare familial cancer predisposition syndromes. Three kindred...

    Authors: Alvin JM Ng, Anthony J Mutsaers, Emma K Baker and Carl R Walkley

    Citation: Clinical Sarcoma Research 2012 2:19

    Content type: Review

    Published on:

  43. Sarcomas were one of the first solid cancers to be linked to ionizing radiation exposure. We reviewed the current evidence on this relationship, focusing particularly on the studies that had individual estimat...

    Authors: Amy Berrington de Gonzalez, Alina Kutsenko and Preetha Rajaraman

    Citation: Clinical Sarcoma Research 2012 2:18

    Content type: Review

    Published on:

  46. Children diagnosed with the hereditary form of retinoblastoma (Rb), a rare eye cancer caused by a germline mutation in the RB1 tumor suppressor gene, have excellent survival, but face an increased risk of bone an...

    Authors: Ruth A Kleinerman, Sara J Schonfeld and Margaret A Tucker

    Citation: Clinical Sarcoma Research 2012 2:15

    Content type: Review

    Published on:

  47. Sarcomas account for over 20% of all pediatric solid malignant cancers and less than 1% of all adult solid malignant cancers. The vast majority of diagnosed sarcomas will be soft tissue sarcomas, while maligna...

    Authors: Zachary Burningham, Mia Hashibe, Logan Spector and Joshua D Schiffman

    Citation: Clinical Sarcoma Research 2012 2:14

    Content type: Review

    Published on:

  49. To evaluate tolerability and maintenance of dose intensity of 2 weekly treatment with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide (VDC/IE) in patients with advanced small ...

    Authors: Jeremy Whelan, Atia Khan, Anand Sharma, Christian Rothermundt, Palma Dileo, Maria Michelagnoli, Beatrice Seddon and Sandra Strausss

    Citation: Clinical Sarcoma Research 2012 2:12

    Content type: Research

    Published on:

  50. Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib : an active agent only in non progressive patients.

    Authors: Florence Duffaud, Caroline Even, Isabelle Ray-Coquard, Emmanuelle Bompas, Thanh Khoa-Huynh, Sebastien Salas, Philippe Cassier, Armelle Dufresne, Sylvie Bonvalot, Francoise Ducimetiere, Axel Le Cesne and Jean-Yves Blay

    Citation: Clinical Sarcoma Research 2012 2:11

    Content type: Research

    Published on:

Submit manuscript

Follow

  • ISSN: 2045-3329 (electronic)

Advertisement

Clinical Sarcoma Research

ISSN: 2045-3329